Looking to expand in medical nutrition, Nestle (OTCPK:NSRGY) is buying Allergan’s (NYSE:AGN) Zenpep, which had sales of $237M in 2018.
The product caters to people who cannot digest
food properly because their pancreas does not provide enough enzymes to
break down fat, protein, and carbohydrates.
“This is a significant opportunity for our
business in the United States to add a complementary product to our
existing range of nutrition products,” said Nestle’s Greg Behar.
https://seekingalpha.com/news/3534546-nestle-scoops-up-allergans-zenpep
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.